M2951

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for M2951, covering 2018-05-30 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: A TQT Study of Effect of M2951 on Cardiac Repolarization [Phase 1]